Genovate Biotechnology Co., LTD.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.genovate-bio.com
Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication
Phase 3
Terminated
- Conditions
- Intermittent Claudication
- Interventions
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 14
- Registration Number
- NCT06886620
- Locations
- 🇨🇳
Cheng Hsin General Hospital, Taipei, Taiwan
🇨🇳Chang Gung Memorial Hospital Linkou, Taoyuan, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Intermittent Claudication
- Interventions
- Drug: PMR Tablet 145 mg
- First Posted Date
- 2023-12-12
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 40
- Registration Number
- NCT06167265
- Locations
- 🇺🇸
Cliantha Research, Saint Petersburg, Florida, United States
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Intermittent Claudication
- Interventions
- Drug: PMR Tablet 135 mg
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 25
- Registration Number
- NCT05466734
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers
Phase 1
Terminated
- Conditions
- Intermittent Claudication
- Interventions
- Drug: PMR 135 mg
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 19
- Registration Number
- NCT05191862
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Intermittent Claudication
- Interventions
- Drug: PMR 200 mg
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 28
- Registration Number
- NCT03864666
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Intermittent Claudication
- Interventions
- First Posted Date
- 2018-03-29
- Last Posted Date
- 2018-07-10
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 21
- Registration Number
- NCT03480321
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Phase 2
Completed
- Conditions
- Lupus Nephritis
- Interventions
- First Posted Date
- 2016-10-31
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 32
- Registration Number
- NCT02949349
Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study
- Conditions
- Uveitis
- Interventions
- First Posted Date
- 2010-12-16
- Last Posted Date
- 2010-12-16
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 40
- Registration Number
- NCT01261169
- Locations
- 🇨🇳
CGMH, Taoyuan County, Taiwan
Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2007-10-10
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 12
- Registration Number
- NCT00541437
- Locations
- 🇨🇳
National Taiwan university hospital, Taipei, Taiwan
Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
Phase 4
- Conditions
- HyperprolactinemiaWeight GainDyslipidemia
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2007-10-10
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Registration Number
- NCT00541554
© Copyright 2025. All Rights Reserved by MedPath